North America Insulin Delivery Market Outlook to 2033 - Insulin Pens and Insulin Pumps

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Insulin Delivery Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Insulin Delivery Market, North America, Revenue ($m), 2018-2033
3.2 Insulin Delivery Market, North America, Revenue ($m), 2018-2033
3.3 Insulin Delivery Market, North America, Volume (Units), 2018-2033
3.4 Insulin Delivery Market, North America, Volume (Units), 2018-2033
3.5 Insulin Delivery Market, North America, Company Share by Revenue ($m), 2023

4.1 Insulin Delivery Market, Canada, Revenue ($m), 2018-2033
4.1.1 Insulin Pens Market, Canada, Revenue ($m), by Segment, 2018-2033
4.1.2 Insulin Pumps Market, Canada, Revenue ($m), by Segment, 2018-2033
4.2 Insulin Delivery Market, Canada, Volume (Units), 2018-2033
4.2.1 Insulin Pens Market, Canada, Volume (Units), by Segment, 2018-2033
4.2.2 Insulin Pumps Market, Canada, Volume (Units), by Segment, 2018-2033
4.3 Insulin Delivery Market, Canada, Average Price ($) , 2018-2033
4.4 Insulin Delivery Market, Canada, Distribution Share by Revenue ($m), 2023
4.5 Insulin Delivery Market, Canada, Company Share by Revenue ($m), 2023

5.1 Insulin Delivery Market, United States, Revenue ($m), 2018-2033
5.1.1 Insulin Pens Market, United States, Revenue ($m), by Segment, 2018-2033
5.1.2 Insulin Pumps Market, United States, Revenue ($m), by Segment, 2018-2033
5.2 Insulin Delivery Market, United States, Volume (Units), 2018-2033
5.2.1 Insulin Pens Market, United States, Volume (Units), by Segment, 2018-2033
5.2.2 Insulin Pumps Market, United States, Volume (Units), by Segment, 2018-2033
5.3 Insulin Delivery Market, United States, Average Price ($) , 2018-2033
5.4 Insulin Delivery Market, United States, Distribution Share by Revenue ($m), 2023
5.5 Insulin Delivery Market, United States, Company Share by Revenue ($m), 2023

6.1 Insulin Delivery Market, Mexico, Revenue ($m), 2018-2033
6.1.1 Insulin Pens Market, Mexico, Revenue ($m), by Segment, 2018-2033
6.1.2 Insulin Pumps Market, Mexico, Revenue ($m), by Segment, 2018-2033
6.2 Insulin Delivery Market, Mexico, Volume (Units), 2018-2033
6.2.1 Insulin Pens Market, Mexico, Volume (Units), by Segment, 2018-2033
6.2.2 Insulin Pumps Market, Mexico, Volume (Units), by Segment, 2018-2033
6.3 Insulin Delivery Market, Mexico, Average Price ($) , 2018-2033
6.4 Insulin Delivery Market, Mexico, Distribution Share by Revenue ($m), 2023
6.5 Insulin Delivery Market, Mexico, Company Share by Revenue ($m), 2023

7.1 Sanofi
7.1.1 Company Overview
7.2 Novo Nordisk AS
7.2.1 Company Overview
7.3 Eli Lilly and Co
7.3.1 Company Overview
7.4 Medtronic Plc
7.4.1 Company Overview
7.5 F. Hoffmann-La Roche Ltd
7.5.1 Company Overview
7.6 Insulet Corp
7.6.1 Company Overview
7.7 Tandem Diabetes Care Inc
7.7.1 Company Overview

9.1 Corporate Communications
9.1.1 Mar 06, 2024: Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
9.1.2 Mar 04, 2024: Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
9.1.3 Mar 04, 2024: Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX
9.2 Financial Announcements
9.2.1 Jan 23, 2025: embecta to Report Fiscal First Quarter 2025 Financial Results
9.2.2 Nov 26, 2024: Embecta Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance
9.2.3 Nov 14, 2024: Retractable Technologies Reports Results for the Periods Ended September 30, 2024
9.2.4 Nov 07, 2024: Nektar Therapeutics Reports Third Quarter 2024 Financial Results
9.2.5 Oct 31, 2024: MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024
9.2.6 Oct 16, 2024: Lilly Confirms Date and Conference Call for Third-Quarter 2024 Financial Results Announcement
9.2.7 Oct 10, 2024: BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results
9.2.8 Sep 26, 2024: Integer Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024
9.2.9 Jul 03, 2024: BD to Announce Financial Results for its Third Quarter of Fiscal 2024
9.2.10 Jun 04, 2024: Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
9.2.11 May 01, 2024: MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024
9.2.12 Apr 16, 2024: Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results
9.2.13 Apr 04, 2024: BD to Announce Financial Results for its Second Quarter of Fiscal 2024
9.2.14 Apr 03, 2024: Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024
9.2.15 Feb 20, 2024: MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024
9.3 Government and Public Interest
9.3.1 Oct 04, 2024: Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference
9.3.2 Apr 29, 2024: BD to Present at Bank of America Securities Health Care Conference 2024
9.3.3 Apr 24, 2024: Merus Announces Presentation MCLA-129 at the 2024 ASCO Annual Meeting
9.3.4 Apr 22, 2024: Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
9.3.5 Apr 02, 2024: Johnson & Johnson to Participate in the BofA Securities Health Care Conference
9.3.6 Mar 04, 2024: Biden-Harris Administration Receives Counteroffers from Drug Companies as Part of Ongoing Negotiations to Lower Drug Prices
9.3.7 Feb 15, 2024: BD to Present at Investor Healthcare Conferences
9.3.8 Feb 14, 2024: Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference
9.3.9 Feb 13, 2024: Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference
9.4 Legal And Regulatory
9.4.1 Aug 14, 2024: Enrollment Completed in Phase 3 Clinical Study of Disitamab Vedotin Combined with PD-1 Inhibitor as First-Line Treatment for Urothelial Carcinoma
9.5 Other Significant Developments
9.5.1 Dec 20, 2024: Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025, Including Market Launch for Barium Suite of Products and Advancement of Iodine Suite
9.6 Product News
9.6.1 Mar 06, 2024: embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes
9.7 Research And Development
9.7.1 Nov 04, 2024: MannKind Successfully Completes Phase 1 Trial of Nintedanib DPI for Pulmonary Fibrotic Diseases

10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Distribution Share Analysis
10.1.7 Benchmarking
10.2 The Publisher's Consulting
10.3 Contact the Publisher
10.4 Disclaimer

Table 1: Insulin Delivery Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Table 2: Insulin Delivery Market, North America, Revenue ($m), USD Constant, 2018-2033
Table 3: Insulin Delivery Market, North America, Volume (Units), 2018-2033
Table 4: Insulin Delivery Market, North America, Volume (Units), 2018-2033
Table 5: Insulin Delivery Market, North America, Company Share by Revenue ($m), USD Constant, 2023
Table 6: Insulin Delivery Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 7: Insulin Pens Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 8: Insulin Pumps Market, Canada, Revenue ($m), USD Constant, 2018-2033
Table 9: Insulin Delivery Market, Canada, Volume (Units), 2018-2033
Table 10: Insulin Pens Market, Canada, Volume (Units), 2018-2033
Table 11: Insulin Pumps Market, Canada, Volume (Units), 2018-2033
Table 12: Insulin Delivery Market, Canada, Average Price ($), 2018-2033
Table 13: Insulin Delivery Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2023
Table 14: Insulin Delivery Market, Canada, Company Share by Revenue ($m), USD Constant, 2023
Table 15: Insulin Delivery Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 16: Insulin Pens Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 17: Insulin Pumps Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 18: Insulin Delivery Market, United States, Volume (Units), 2018-2033
Table 19: Insulin Pens Market, United States, Volume (Units), 2018-2033
Table 20: Insulin Pumps Market, United States, Volume (Units), 2018-2033
Table 21: Insulin Delivery Market, United States, Average Price ($), 2018-2033
Table 22: Insulin Delivery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 23: Insulin Delivery Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 24: Insulin Delivery Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 25: Insulin Pens Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 26: Insulin Pumps Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Table 27: Insulin Delivery Market, Mexico, Volume (Units), 2018-2033
Table 28: Insulin Pens Market, Mexico, Volume (Units), 2018-2033
Table 29: Insulin Pumps Market, Mexico, Volume (Units), 2018-2033
Table 30: Insulin Delivery Market, Mexico, Average Price ($), 2018-2033
Table 31: Insulin Delivery Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2023
Table 32: Insulin Delivery Market, Mexico, Company Share by Revenue ($m), USD Constant, 2023
Table 33: Insulin Delivery Market Pipeline Products

Figure 1: Insulin Delivery Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033
Figure 2: Insulin Delivery Market, North America, Revenue ($m), USD Constant, 2018-2033
Figure 3: Insulin Delivery Market, North America, Volume (Units), 2018-2033
Figure 4: Insulin Delivery Market, North America, Volume (Units), 2018-2033
Figure 5: Insulin Delivery Market, North America, Company Share (%) 2023
Figure 6: Insulin Delivery Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 7: Insulin Pens Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 8: Insulin Pumps Market, Canada, Revenue ($m), USD Constant, 2018-2033
Figure 9: Insulin Delivery Market, Canada, Volume (Units), 2018-2033
Figure 10: Insulin Pens Market, Canada, Volume (Units), 2018-2033
Figure 11: Insulin Pumps Market, Canada, Volume (Units), 2018-2033
Figure 12: Insulin Delivery Market, Canada, Company Share (%) 2023
Figure 13: Insulin Delivery Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 14: Insulin Pens Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 15: Insulin Pumps Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 16: Insulin Delivery Market, United States, Volume (Units), 2018-2033
Figure 17: Insulin Pens Market, United States, Volume (Units), 2018-2033
Figure 18: Insulin Pumps Market, United States, Volume (Units), 2018-2033
Figure 19: Insulin Delivery Market, United States, Company Share (%) 2023
Figure 20: Insulin Delivery Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 21: Insulin Pens Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 22: Insulin Pumps Market, Mexico, Revenue ($m), USD Constant, 2018-2033
Figure 23: Insulin Delivery Market, Mexico, Volume (Units), 2018-2033
Figure 24: Insulin Pens Market, Mexico, Volume (Units), 2018-2033
Figure 25: Insulin Pumps Market, Mexico, Volume (Units), 2018-2033
Figure 26: Insulin Delivery Market, Mexico, Company Share (%) 2023